Quantril

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 534968

CAS#: 23844-24-8

Description: Quantril is a bioactive chemical.


Chemical Structure

img
Quantril
CAS# 23844-24-8

Theoretical Analysis

MedKoo Cat#: 534968
Name: Quantril
CAS#: 23844-24-8
Chemical Formula: C22H32N2O5
Exact Mass: 404.23
Molecular Weight: 404.507
Elemental Analysis: C, 65.32; H, 7.97; N, 6.93; O, 19.78

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Quantril

IUPAC/Chemical Name: 2H-Benzo(a)quinolizine-3-carboxamide, 2-(acetyloxy)-N,N-diethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-, (2alpha,3beta,11balpha)- (9CI)

InChi Key: JSZILQVIPPROJI-CEXWTWQISA-N

InChi Code: InChI=1S/C22H32N2O5/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25/h10-11,17-19H,6-9,12-13H2,1-5H3/t17-,18+,19-/m1/s1

SMILES Code: O=C([C@@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@]2([H])C[C@H]1OC(C)=O)N(CC)CC

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 404.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ricci V, Delgado Nunes V, Murphy MS, Cunningham S; Guideline Development Group and Technical Team. Bronchiolitis in children: summary of NICE guidance. BMJ. 2015 Jun 2;350:h2305. doi: 10.1136/bmj.h2305. PMID: 26037525.


2: Diacon AH, Pym A, Grobusch MP, de los Rios JM, Gotuzzo E, Vasilyeva I, Leimane V, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, De Paepe E, van Heeswijk RP, Dannemann B; TMC207-C208 Study Group. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med. 2014 Aug 21;371(8):723-32. doi: 10.1056/NEJMoa1313865. PMID: 25140958.


3: Wiener RS, Schwartz LM, Woloshin S. Authors' reply to Quantrill, Benger, Ripley and colleagues, Roach, Rogers, and Haldar and colleagues. Version 2. BMJ. 2013 Aug 20;347:f5131. doi: 10.1136/bmj.f5131. PMID: 23963558; PMCID: PMC4688543.


4: Saleh A, López-Campos JL, Hartl S, Pozo-Rodríguez F, Roberts CM; European COPD Audit team. The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit. PLoS One. 2015 Jul 27;10(7):e0134004. doi: 10.1371/journal.pone.0134004. PMID: 26214175; PMCID: PMC4516303.


5: Ho MW, Pick AS, Sutton DN, Dyker K, Cardale K, Gilbert K, Johnson J, Quantrill J, McCaul JA. Recruitment of patients into head and neck clinical trials: acceptability of studies to patients from perspective of the research team. Br J Oral Maxillofac Surg. 2018 May;56(4):278-282. doi: 10.1016/j.bjoms.2018.02.005. Epub 2018 Mar 6. PMID: 29523362.


6: Quantrill SJ, Tun JK. Workplace-based assessment as an educational tool. Guide supplement 31.5--Viewpoint. Med Teach. 2012;34(5):417-8. doi: 10.3109/0142159X.2012.668234. Epub 2012 Mar 29. PMID: 22458295.


7: Tittle V, Randall D, Maheswaran V, Webb A, Quantrill S, Roberts M. Practical prescribing course: a student evaluation. Clin Teach. 2014 Feb;11(1):38-42. doi: 10.1111/tct.12106. PMID: 24405918.


8: Quantrill SJ. Risk-benefit ratio favours treating all pulmonary emboli, no matter how small. BMJ. 2013 Aug 20;347:f5121. doi: 10.1136/bmj.f5121. PMID: 23963556.


9: Quantrill S, Webbe D. Including pharmacists on consultant-led ward rounds. Clin Med (Lond). 2011 Dec;11(6):627-8; author reply 628. doi: 10.7861/clinmedicine.11-6-627. PMID: 22268327; PMCID: PMC4952354.


10: Quantrill D, Riordan A. Parents' and carers' perceptions of acute paediatric admissions. Arch Dis Child. 2014 Aug;99(8):706-7. doi: 10.1136/archdischild-2014-306517. Epub 2014 Jun 9. PMID: 24914096.


11: Fields E, Chard J, Murphy MS, Richardson M; Guideline Development Group and Technical Team. Assessment and initial management of feverish illness in children younger than 5 years: summary of updated NICE guidance. BMJ. 2013 May 22;346:f2866. doi: 10.1136/bmj.f2866. PMID: 23697671.


12: Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial cells. Lancet. 1988 Mar 5;1(8584):535-6. doi: 10.1016/s0140-6736(88)91332-3. PMID: 2893953.


13: Quantrill SJ, Archer GJ, Hale RJ. Gastric tuberculosis presenting with massive hematemesis in association with acute myeloid leukemia. Am J Gastroenterol. 1996 Jun;91(6):1259-60. PMID: 8651184.


14: Teh LB, Stopard M, Anderson S, Grant A, Quantrill D, Wilkinson RH, Jewell DP. Assessment of fat malabsorption. J Clin Pathol. 1983 Dec;36(12):1362-6. doi: 10.1136/jcp.36.12.1362. PMID: 6655068; PMCID: PMC498569.


15: Ziso B, Quantrill SJ. Abnormal chest radiograph in pregnancy. BMJ. 2011 Oct 17;343:d6035. doi: 10.1136/bmj.d6035. PMID: 22006941.


16: Sharma A, Quantrill NS. alpha-Ketoglutarate assay based on fluorescence quenching by NADH. Biotechnol Prog. 1996 May-Jun;12(3):413-6. doi: 10.1021/bp960027f. PMID: 8652126.


17: Quantrill SJ, Dabal L. Transudates and exudates. Thorax. 2002 Jul;57(7):657; author reply 657-8. doi: 10.1136/thorax.57.7.657-a. PMID: 12096213; PMCID: PMC1746375.


18: Padayatchi N, Quantrill J. Treat the patient, not the result. S Afr Med J. 2009 Jun;99(6):412. PMID: 19736836.


19: Nour EM, Cherian BP, Quantrill SJ. Diagnostic yield of early morning urine samples in the diagnosis of tuberculosis. QJM. 2007 Jul;100(7):464-5. doi: 10.1093/qjmed/hcm047. Epub 2007 Jun 12. PMID: 17566007.


20: Quantrill SJ, White R, Crawford A, Barry JS, Batra S, Whyte P, Roberts CM. Short burst oxygen therapy after activities of daily living in the home in chronic obstructive pulmonary disease. Thorax. 2007 Aug;62(8):702-5. doi: 10.1136/thx.2006.063636. Epub 2007 Feb 20. PMID: 17311844; PMCID: PMC2117261.